Literature DB >> 6467029

Loss of intrinsic striatal neurons after methylazoxymethanol acetate treatment in pregnant rats.

W Balduini, M P Abbracchio, G Lombardelli, F Cattabeni.   

Abstract

Treatment of pregnant rats with methylazoxymethanol (MAM) induces a marked microencephaly in the offspring. The striatum is one of the brain areas affected by treatment. We show that in striatum there is a 30% loss of dopamine (DA)-dependent adenylate-cyclase activity: this indicates that cells bearing type 1 DA receptors are affected by MAM treatment. Moreover, since kainic acid retains its neurotoxic activity, corticostriatal fibers do not seem to be affected, despite the dramatic reduction of cortex size.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467029     DOI: 10.1016/0165-3806(84)90149-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.

Authors:  M Watanabe; M Kinuya; G Mamiya; T Tatsunuma; M Nagayoshi; T Matsutani; Y Tsukada
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

2.  Effect of prenatal treatment with methylazoxymethanol on carbachol-, norepinephrine- and glutamate-stimulated phosphoinositide metabolism in the neonatal, young, and adult offspring.

Authors:  W Balduini; G Lombardelli; G Peruzzi; F Cattabeni
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

3.  Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.

Authors:  P Johansson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Cholinergic hyperinnervation in the cerebral cortex of microencephalic rats does not result in muscarinic receptor down-regulation or in alteration of receptor-stimulated phosphoinositide metabolism.

Authors:  W Balduini; G Lombardelli; G Peruzzi; F Cattabeni
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

Review 5.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.